Brands
Harpic’s #MomWaliDiwali campaign celebrates family bonds
Mumbai: Harpic Bathroom Cleaner, India’s leading bathroom cleaning brand released its first-ever festive campaign #MomWaliDiwali, inspiring families to play a bigger role in getting homes ready for the upcoming festival of lights. The heartwarming campaign highlights how each member can support the homemaker in this process, especially when it comes to bathroom cleaning.
Diwali cleaning is a ritual India takes very seriously and the entire family comes together to take part in the activity under the supervision of the homemaker who is the protagonist and adds to perfection everywhere (Mom’s perfect touch). However, when it comes to cleaning a bathroom, which is the most tedious job of all, homemakers are usually left alone to complete the job. The joy of the celebrations can be manifold if the family pitches in to help her in this job as well.
Reckitt regional marketing director, South Asia – hygiene Saurabh Jain said, “Harpic, popular for its direct communication with consumers, has adopted a unique approach to the festive season this year. In a new direction for the brand, Harpic Bathroom Cleaner through #MomWaliDiwali, showcases the importance of a mother’s touch in achieving perfection in every task, and the role families can play to ease her work around the house, especially during Diwali cleaning. The heartwarming brand film aims to bring families together in the most mundane task of cleaning. We are excited to see how consumers receive the film, an effort to create a unique brand recall moment amongst them.”
The campaign video beautifully captures the significance of a mother’s touch in achieving perfection in every task, big or small, while encouraging family members to assist mothers with exhausting tasks like bathroom cleaning. It features a daughter, son, and father struggling at tasks like making laddoos, picking right clothes for Diwali, and putting up lights in preparation for Diwali, however, with the mother’s magical touch, they are able to complete the tasks successfully. When the mother is later seen attempting to clean the bathroom, the son, daughter and father intervene to help, using the Harpic Bathroom Cleaner, making the mother smile in awe of her family.
Harpic is synonymous with clean and hygienic bathrooms and an essential tool that every homemaker relies on. Harpic Bathroom Cleaner gives 10X better cleaning^ with less effort when compared to ordinary detergents and kills 99.9% germs*, leaving behind shiny, and clean bathrooms with a pleasant fragrance, reinstating its proposition of #HarpicDegaSaath. The brand campaign video is available on Harpic’s official YouTube page and is being run on YouTube, Meta and Disney+ Hotstar.
*Kills 99.9% germs post 5 minutes of contact time with diluted or neat product
^Vs ordinary detergent powders under standard test conditions
Brands
Sun Pharma to acquire Organon in $11.75 billion deal at $14 per share
Acquisition to create $12.4 billion pharma giant with global scale and biosimilars push
MUMBAI: Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest cross-border pharma acquisitions by an Indian firm.
Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, with Sun Pharma set to acquire 100 per cent of the company’s outstanding shares. The transaction, approved by the boards of both companies, is expected to close in early 2027, subject to regulatory approvals and shareholder consent.
The deal significantly expands Sun Pharma’s global footprint and strengthens its position across women’s health, biosimilars, and branded generics. The combined entity is projected to generate revenues of around $12.4 billion, placing it among the top 25 pharmaceutical companies globally.
Organon, which was spun off from Merck in 2021, brings a portfolio of over 70 products spanning women’s health and general medicines, with operations across more than 140 countries. Its established presence in key markets such as the US, Europe, and China complements Sun Pharma’s existing strengths and growth ambitions.
Sun Pharmaceutical Industries Limited executive chairman Dilip Shanghvi said, “This transaction represents a significant opportunity for Sun Pharma to build on its vision of reaching people and touching lives. Organon’s portfolio, capabilities and global reach are highly complementary to our own.”
Sun Pharmaceutical Industries Limited managing director Kirti Ganorkar added, “This transaction is a logical next step in strengthening Sun Pharma’s global business. Together, we will become a partner of choice for acquiring and launching new products.”
From Organon’s side, Organon & Co. executive chair Carrie Cox noted, “This all-cash transaction offers compelling and immediate value to Organon stockholders, while positioning the business for continued growth under Sun Pharma.”
Strategically, the acquisition gives Sun Pharma entry into the global biosimilars space as a top 10 player and strengthens its innovative medicines portfolio, which is expected to contribute around 27 per cent of combined revenues. The deal is also expected to nearly double EBITDA and cash flow, supporting long-term deleveraging and investment capacity.
Sun Pharma plans to fund the acquisition through a mix of internal accruals and committed financing from global banks, while maintaining focus on disciplined integration and operational continuity post-merger.
If completed as planned, the deal signals a clear shift in India’s pharmaceutical ambitions, from scale at home to leadership on the global stage, with Sun Pharma positioning itself as a more diversified and innovation-led healthcare powerhouse.
